Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy
Yang Liu,1 Zhengyuan Zhou,2 Yutian Feng,2 Xiao-Guang Zhao,2 Ganesan Vaidyanathan,2 Michael R Zalutsky,1,2 Tuan Vo-Dinh1,3,4 1Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA; 2Department of Radiology, Duke University Medical Center, Durham, NC, 27710, USA; 3Department of...
Enregistré dans:
Auteurs principaux: | Liu Y, Zhou Z, Feng Y, Zhao XG, Vaidyanathan G, Zalutsky MR, Vo-Dinh T |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5d2911eaef9b4861bfe2d09d6ac7c17e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars
par: Crawford BM, et autres
Publié: (2017) -
Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy
par: Si Chen, et autres
Publié: (2021) -
Enhancing the Therapeutic Effect of 2-<sup>211</sup>At-astato-α-methyl-L-phenylalanine with Probenecid Loading
par: Hirofumi Hanaoka, et autres
Publié: (2021) -
Biodistribution and sensitive tracking of immune cells with plasmonic gold nanostars
par: Liu Y, et autres
Publié: (2019) -
Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging
par: D’Hollander A, et autres
Publié: (2016)